Blog / Archives
JPMorgan Healthcare Conference: Life Science Tools Rally
Life Science stocks got a boost from news and presentations at the J.P.Morgan Healthcare Conference and most stocks from the Rayno Life Science Portfolio were up.(see our "January Effect" trades...
Rayno SnowBlog: High and Dry- Dry Curse of La Nina is Back 1/31
We had a powder weekend in Mammoth with 3ft Jan20-22 but nothing on the horizon for 10 days. Check Alta, Northwest like Mt Baker or BC and maybe Big Sky....
Biotechnology Stock Review 2011:Update 1/2/12
Here are some key points from our 2011 Biotech Stock Review posted in Investor Uprising: Winners from the 2011 Rayno Life Science Portfolio: Abaxis (ABAX), Alexion(ALXN), Amgen (AMGN), Biogen(BIIB),...
Rayno Diagnostics and Tools Portfolio: ILMN, NEOG
Life Sciences: Biopharmaceutical Stocks are Hot, Tools and DX are Not We recommended avoiding the Tools/Dx sector several weeks ago as they were lagging biopharmaceutical stocks due to earnings...
Three Small Cap Stocks for a Rebound in January: AMRI,ASTX,SRLS-UPDATE 1/5/12
January Rally on Schedule for Small Cap Biotech Stocks Three Picks we made on December 14: Albany Molecular (AMRI $2.89) Up 16% Astex Pharmaceuticals (ASTX $1.94) Up 19% SeraCare (SRLS $3.00) Up...
Macro News Kills Holiday Buzz: Markets Off 1.6% and More
Rally Hits a Wall at S&P Q4 High of 1265, Down 2% to 1237 You have heard all the compelling reasons to jump into this market: Seasonality is strong from November through May Charts look good...
Rayno Life Science Portfolio: Tools Rally- A, LIFE, ILMN, QGEN
Illumina (ILMN $30.23) shares spiked today on takeover speculation. The shares were whacked in July and the stock is down 52% YTD on an earnings miss with no guidance. Revenue estimates from...
Pure Play Diagnostics Roster: Metrics with Q3 Earnings
No new buys, currently on HOLD list: ABAX, EXAS, NEOG, QDEL, SRLS. Rayno Life Science Tools And Dx Portfolio Update:Immucor Beats 6/20 update | Raygent.com Outperformers YTD: ABAX up 2.9%,CPHD up...
Macro “Risk On”: Life Science Stock Follow Up 3.4%
Rayno Life Science Portfolios Up 3.4% Two big up days this week were driven primarily by high expectations by Central Bank coordination to cut the cost of emergency dollar funding and news from the...
Rayno Life Science Portfolios Run With NASDAQ Up 3.79%
Life Science Stocks Have a Big Day The Rayno Biopharmaceutical Portfolio was up over 3.7% today as all biotechnology stocks pretty much tracked NASDAQ which was up 3.5%. Although we remain cautious...